TABLE 8.
The clusters information of co-cited references on APS.
| Cluster ID | Size | Silhouette | Label (LLR) | Mean year |
|---|---|---|---|---|
| #0 | 116 | 0.865 | Vitamin K antagonists | 2017 |
| #1 | 106 | 0.797 | Agapss | 2014 |
| #2 | 100 | 0.831 | Catastrophic antiphospholipid syndrome | 2011 |
| #3 | 87 | 0.842 | Beta (2)-glycoprotein I | 2009 |
| #4 | 86 | 0.791 | Pregnancy | 2015 |
| #5 | 55 | 0.835 | Risk factors | 2010 |
| #6 | 39 | 0.903 | Immunoglobulin A | 2018 |
| #7 | 36 | 0.912 | Rivaroxaban | 2014 |
| #8 | 19 | 0.944 | Signal transduction | 2015 |
| #9 | 6 | 0.994 | Anti-annexin A5 antibodies | 2013 |
Rank: based on the size. “Size” denotes the amount of co-cited references that a cluster contains. LLR: log-likelihood ratio.